Firmenbeschreibung
Qiagen N.V. ist eine niederländische Holdinggesellschaft und weltweit führend in der Entwicklung und Herstellung innovativer Technologien und Produkte für die präanalytische Probenvorbereitung und molekularbiologischen Tests für die Forschung in Life Sciences, dem Feld der angewandten Testverfahren und der molekularen Diagnostik. Das umfangreiche Portfolio des Unternehmens umfasst zahlreiche Produkte und Automationsplattformen für die Probenentnahme sowie die Trennung, Reinigung und Handhabung von Nukleinsäuren und Proteinen sowie Testtechnologien, die in der Form von offenen Nachweiskits und auch gezielten Tests für die angewandten Märkte und die molekulare Diagnostik angeboten werden. Qiagen-Produkte werden an wissenschaftliche Forschungsinstitute, Unternehmen im Pharma- und Biotechnologiebereich, an Kunden in angewandten Märkten (u.a. Forensik, Tier- und Nahrungsmittelkontrolle und der pharmazeutischen Prozesskontrolle) sowie an diagnostische Labore verkauft.
KeyData
endOfFinancialYear: | 31.12.2022 00:00 |
stockholderStructure: | BlackRock, Inc. (14%),Sun Life Financial, Inc. (MFS) (9.7%),The Vanguard Group, Inc. (3.7%),Rue la Boetie SAS (3.3%),Goldman Sachs & Co. LLC (3.3%),State Street Corp. (3.3%) |
sharesOutstanding: | 227074000.0000 |
ceo: | Thierry Bernard |
board: | Roland Sackers, Dr. Jonathan Sheldon, Dr. Thomas Schweins, Jean-Pascal Viola, Stephany Foster, Antonio Santos |
supervisoryBoard: | Lawrence A. Rosen, Dr. Metin Colpan, Dr. Toralf Haag, Elizabeth E. Tallett, Prof. Dr. Elaine Mardis, Prof. Dr. Ross L. Levine, Thomas Ebeling, Dr. Eva Pisa, Steve Rusckowski |
countryID: | 4 |
freeFloat: | 60.0000 |
faceValue: | 0.0100 |
faceValueCurrencyID: | 4 |
faceValueCurrency: | USD |
sectorName: | Biotechnologie |
industryName: | Biotechnologie |
subsectorName: | Biotechnologie |
country: | Niederlande |
countryName: | Niederlande |
Kontakt
name: | John Gilardi |
phone: | +49-2103-29-11711 |
email: | john.gilardi@qiagen.com |
irWebSite: | https://corporate.qiagen.com/investor-relations/ |
Adresse
street: | Spoorstraat 50 |
city: | NL-5911 KJ Venlo |
phone: | +31-77-320-8400 |
fax: | +31-77-320-8409 |
webSite: | www.qiagen.com |
email: | qiagen@qiagen.com |
Finanzen (kurz)
year: | 2020 | cash: | 598.0000 |
balanceSheetTotal: | 5912.5000 | liabilities: | 3114.7000 |
totalShareholdersEquity: | 2797.8000 | sales: | 1870.3000 |
bankLoans: | 407.2000 | investment: | 10.0000 |
incomeBeforeTaxes: | 439.5000 | netIncome: | 359.2000 |
cashFlow: | -31.4000 | employees: | 5610 |
currencyID: | 4 | units: | 1000000 |
currency: | USD |
year: | 2021 | cash: | 880.5000 |
balanceSheetTotal: | 6147.0000 | liabilities: | 3050.4000 |
totalShareholdersEquity: | 3096.6000 | sales: | 2251.7000 |
bankLoans: | 648.6000 | investment: | 9.6000 |
incomeBeforeTaxes: | 625.8000 | netIncome: | 512.6000 |
cashFlow: | 282.5000 | employees: | 6028 |
currencyID: | 4 | units: | 1000000 |
currency: | USD |
year: | 2022 | cash: | 730.6600 |
balanceSheetTotal: | 6287.7300 | liabilities: | 2821.1200 |
totalShareholdersEquity: | 3466.6100 | sales: | 2141.5100 |
investment: | 32.7500 | incomeBeforeTaxes: | 512.6000 |
netIncome: | 423.2100 | employees: | 6178 |
currencyID: | 4 | units: | 1000000 |
currency: | USD |
Finanzen (kurz)
year: | 2020 |
cash: | 598.0000 |
balanceSheetTotal: | 5912.5000 |
liabilities: | 3114.7000 |
totalShareholdersEquity: | 2797.8000 |
sales: | 1870.3000 |
bankLoans: | 407.2000 |
investment: | 10.0000 |
incomeBeforeTaxes: | 439.5000 |
netIncome: | 359.2000 |
cashFlow: | -31.4000 |
employees: | 5610 |
currencyID: | 4 |
units: | 1000000 |
currency: | USD |
year: | 2021 |
cash: | 880.5000 |
balanceSheetTotal: | 6147.0000 |
liabilities: | 3050.4000 |
totalShareholdersEquity: | 3096.6000 |
sales: | 2251.7000 |
bankLoans: | 648.6000 |
investment: | 9.6000 |
incomeBeforeTaxes: | 625.8000 |
netIncome: | 512.6000 |
cashFlow: | 282.5000 |
employees: | 6028 |
currencyID: | 4 |
units: | 1000000 |
currency: | USD |
year: | 2022 |
cash: | 730.6600 |
balanceSheetTotal: | 6287.7300 |
liabilities: | 2821.1200 |
totalShareholdersEquity: | 3466.6100 |
sales: | 2141.5100 |
investment: | 32.7500 |
incomeBeforeTaxes: | 512.6000 |
netIncome: | 423.2100 |
employees: | 6178 |
currencyID: | 4 |
units: | 1000000 |
currency: | USD |
Finanzen (ausführlich)
year: | 2021 | units: | 1000000 |
balanceSheetTotal: | 6147.0000 | cash: | 880.5000 |
currentAssets: | 2109.6000 | fixedAssets: | 4037.4000 |
liabilities: | 1517.5000 | nonCurrentLiabilities: | 1532.9000 |
totalLiabilitiesEquity: | 6147.0000 | provisions: | 606.2000 |
totalShareholdersEquity: | 3096.6000 | employees: | 6028 |
property: | 638.2000 | intangibleAssets: | 627.4000 |
inventories: | 327.5000 | accountsReceivable: | 362.1000 |
currentSecurities: | 184.8000 | accountsPayable: | 101.2000 |
liabilitiesBanks: | 0.0000 | liabilitiesTotal: | 3050.4000 |
shortTermDebt: | 0.0000 | minorityInterests: | 0.0000 |
sales: | 2251.7000 | depreciation: | 18.5000 |
netIncome: | 512.6000 | operatingResult: | 630.1000 |
ebitda: | 648.6000 | incomeInterest: | -44.9000 |
investments: | 190.0000 | incomeTaxes: | 113.2000 |
costGoodsSold: | 800.8000 | grossProfit: | 1450.8000 |
minorityInterestsProfit: | 0.0000 | revenuePerEmployee: | 373540.1460 |
cashFlow: | 639.0000 | cashFlowInvesting: | -202.4000 |
cashFlowFinancing: | -150.4000 | cashFlowTotal: | 282.5000 |
accountingStandard: | US GAAP | equityRatio: | 50.3758 |
debtEquityRatio: | 98.5080 | liquidityI: | 70.2010 |
liquidityII: | 94.0626 | netMargin: | 22.7650 |
grossMargin: | 64.4313 | cashFlowMargin: | 28.3786 |
ebitMargin: | 27.9833 | ebitdaMargin: | 28.8049 |
preTaxROE: | 20.2093 | preTaxROA: | 10.1806 |
roe: | 16.5536 | roa: | 8.3390 |
netIncomeGrowth: | 42.7060 | revenuesGrowth: | 20.3925 |
taxExpenseRate: | 18.0888 | equityTurnover: | 0.7272 |
epsBasic: | 2.2500 | epsDiluted: | 2.2100 |
epsBasicGrowth: | 43.3121 | incomeBeforeTaxes: | 625.8000 |
priceEarningsRatioCompany: | 24.7022 | priceCashFlowRatio: | 19.8299 |
bookValuePerShare: | 13.5826 | marketCap: | 12671295140.0000 |
earningsYield: | 4.0482 | pegRatio: | 0.5703 |
cashFlowPerShare: | 2.8028 | netAssetsPerShare: | 13.5826 |
priceBookValueRatio: | 4.0920 | priceEarningsRatio: | 24.7197 |
netEarningsPerShare: | 2.2484 | currency: | USD |
year: | 2022 | units: | 1000000 |
balanceSheetTotal: | 6287.7300 | cash: | 730.6600 |
currentAssets: | 2393.9500 | fixedAssets: | 3893.7800 |
liabilities: | 974.5200 | nonCurrentLiabilities: | 1846.6000 |
totalLiabilitiesEquity: | 6287.7300 | provisions: | 486.2300 |
totalShareholdersEquity: | 3466.6100 | employees: | 6178 |
property: | 662.1700 | intangibleAssets: | 544.7900 |
inventories: | 357.9600 | accountsReceivable: | 323.7500 |
accountsPayable: | 98.7300 | liabilitiesTotal: | 2821.1200 |
longTermDebt: | 1474.8900 | shortTermDebt: | 389.5500 |
minorityInterests: | 0.0000 | sales: | 2141.5100 |
netIncome: | 423.2100 | operatingResult: | 531.4600 |
incomeInterest: | -25.6000 | investments: | 189.8500 |
incomeTaxes: | 89.3900 | costGoodsSold: | 756.9500 |
grossProfit: | 1384.5600 | minorityInterestsProfit: | 0.0000 |
revenuePerEmployee: | 346634.8333 | cashFlow: | 715.2600 |
cashFlowInvesting: | -726.7600 | cashFlowFinancing: | -125.8000 |
accountingStandard: | US GAAP | equityRatio: | 55.1329 |
debtEquityRatio: | 81.3798 | liquidityI: | 74.9764 |
liquidityII: | 108.1979 | netMargin: | 19.7622 |
grossMargin: | 64.6534 | cashFlowMargin: | 33.3998 |
ebitMargin: | 24.8171 | ebitdaMargin: | 0.0000 |
preTaxROE: | 14.7868 | preTaxROA: | 8.1524 |
roe: | 12.2082 | roa: | 6.7307 |
netIncomeGrowth: | -17.4385 | revenuesGrowth: | -4.8936 |
taxExpenseRate: | 17.4385 | equityTurnover: | 0.6178 |
epsBasic: | 1.8600 | epsBasicGrowth: | -17.3333 |
incomeBeforeTaxes: | 512.6000 | priceEarningsRatioCompany: | 25.2581 |
priceCashFlowRatio: | 14.9478 | bookValuePerShare: | 15.2327 |
marketCap: | 10691567460.0000 | earningsYield: | 3.9591 |
pegRatio: | -1.4572 | cashFlowPerShare: | 3.1429 |
netAssetsPerShare: | 15.2327 | priceBookValueRatio: | 3.0842 |
priceEarningsRatio: | 25.2630 | netEarningsPerShare: | 1.8596 |
currency: | USD |
year: | 2023 | priceEarningsRatioCompany: | 22.1667 |
priceCashFlowRatio: | 13.1183 | bookValuePerShare: | 15.2327 |
marketCap: | 9382999710.0000 | earningsYield: | 4.5113 |
pegRatio: | -1.2788 | cashFlowPerShare: | 3.1429 |
netAssetsPerShare: | 15.2327 | priceBookValueRatio: | 2.7067 |
priceEarningsRatio: | 22.1710 | netEarningsPerShare: | 1.8596 |
currency: | USD |
Finanzen (ausführlich)
year: | 2021 |
units: | 1000000 |
balanceSheetTotal: | 6147.0000 |
cash: | 880.5000 |
currentAssets: | 2109.6000 |
fixedAssets: | 4037.4000 |
liabilities: | 1517.5000 |
nonCurrentLiabilities: | 1532.9000 |
totalLiabilitiesEquity: | 6147.0000 |
provisions: | 606.2000 |
totalShareholdersEquity: | 3096.6000 |
employees: | 6028 |
property: | 638.2000 |
intangibleAssets: | 627.4000 |
inventories: | 327.5000 |
accountsReceivable: | 362.1000 |
currentSecurities: | 184.8000 |
accountsPayable: | 101.2000 |
liabilitiesBanks: | 0.0000 |
liabilitiesTotal: | 3050.4000 |
shortTermDebt: | 0.0000 |
minorityInterests: | 0.0000 |
sales: | 2251.7000 |
depreciation: | 18.5000 |
netIncome: | 512.6000 |
operatingResult: | 630.1000 |
ebitda: | 648.6000 |
incomeInterest: | -44.9000 |
investments: | 190.0000 |
incomeTaxes: | 113.2000 |
costGoodsSold: | 800.8000 |
grossProfit: | 1450.8000 |
minorityInterestsProfit: | 0.0000 |
revenuePerEmployee: | 373540.1460 |
cashFlow: | 639.0000 |
cashFlowInvesting: | -202.4000 |
cashFlowFinancing: | -150.4000 |
cashFlowTotal: | 282.5000 |
accountingStandard: | US GAAP |
equityRatio: | 50.3758 |
debtEquityRatio: | 98.5080 |
liquidityI: | 70.2010 |
liquidityII: | 94.0626 |
netMargin: | 22.7650 |
grossMargin: | 64.4313 |
cashFlowMargin: | 28.3786 |
ebitMargin: | 27.9833 |
ebitdaMargin: | 28.8049 |
preTaxROE: | 20.2093 |
preTaxROA: | 10.1806 |
roe: | 16.5536 |
roa: | 8.3390 |
netIncomeGrowth: | 42.7060 |
revenuesGrowth: | 20.3925 |
taxExpenseRate: | 18.0888 |
equityTurnover: | 0.7272 |
epsBasic: | 2.2500 |
epsDiluted: | 2.2100 |
epsBasicGrowth: | 43.3121 |
incomeBeforeTaxes: | 625.8000 |
priceEarningsRatioCompany: | 24.7022 |
priceCashFlowRatio: | 19.8299 |
bookValuePerShare: | 13.5826 |
marketCap: | 12671295140.0000 |
earningsYield: | 4.0482 |
pegRatio: | 0.5703 |
cashFlowPerShare: | 2.8028 |
netAssetsPerShare: | 13.5826 |
priceBookValueRatio: | 4.0920 |
priceEarningsRatio: | 24.7197 |
netEarningsPerShare: | 2.2484 |
currency: | USD |
year: | 2022 |
units: | 1000000 |
balanceSheetTotal: | 6287.7300 |
cash: | 730.6600 |
currentAssets: | 2393.9500 |
fixedAssets: | 3893.7800 |
liabilities: | 974.5200 |
nonCurrentLiabilities: | 1846.6000 |
totalLiabilitiesEquity: | 6287.7300 |
provisions: | 486.2300 |
totalShareholdersEquity: | 3466.6100 |
employees: | 6178 |
property: | 662.1700 |
intangibleAssets: | 544.7900 |
inventories: | 357.9600 |
accountsReceivable: | 323.7500 |
accountsPayable: | 98.7300 |
liabilitiesTotal: | 2821.1200 |
longTermDebt: | 1474.8900 |
shortTermDebt: | 389.5500 |
minorityInterests: | 0.0000 |
sales: | 2141.5100 |
netIncome: | 423.2100 |
operatingResult: | 531.4600 |
incomeInterest: | -25.6000 |
investments: | 189.8500 |
incomeTaxes: | 89.3900 |
costGoodsSold: | 756.9500 |
grossProfit: | 1384.5600 |
minorityInterestsProfit: | 0.0000 |
revenuePerEmployee: | 346634.8333 |
cashFlow: | 715.2600 |
cashFlowInvesting: | -726.7600 |
cashFlowFinancing: | -125.8000 |
accountingStandard: | US GAAP |
equityRatio: | 55.1329 |
debtEquityRatio: | 81.3798 |
liquidityI: | 74.9764 |
liquidityII: | 108.1979 |
netMargin: | 19.7622 |
grossMargin: | 64.6534 |
cashFlowMargin: | 33.3998 |
ebitMargin: | 24.8171 |
ebitdaMargin: | 0.0000 |
preTaxROE: | 14.7868 |
preTaxROA: | 8.1524 |
roe: | 12.2082 |
roa: | 6.7307 |
netIncomeGrowth: | -17.4385 |
revenuesGrowth: | -4.8936 |
taxExpenseRate: | 17.4385 |
equityTurnover: | 0.6178 |
epsBasic: | 1.8600 |
epsBasicGrowth: | -17.3333 |
incomeBeforeTaxes: | 512.6000 |
priceEarningsRatioCompany: | 25.2581 |
priceCashFlowRatio: | 14.9478 |
bookValuePerShare: | 15.2327 |
marketCap: | 10691567460.0000 |
earningsYield: | 3.9591 |
pegRatio: | -1.4572 |
cashFlowPerShare: | 3.1429 |
netAssetsPerShare: | 15.2327 |
priceBookValueRatio: | 3.0842 |
priceEarningsRatio: | 25.2630 |
netEarningsPerShare: | 1.8596 |
currency: | USD |
year: | 2023 |
priceEarningsRatioCompany: | 22.1667 |
priceCashFlowRatio: | 13.1183 |
bookValuePerShare: | 15.2327 |
marketCap: | 9382999710.0000 |
earningsYield: | 4.5113 |
pegRatio: | -1.2788 |
cashFlowPerShare: | 3.1429 |
netAssetsPerShare: | 15.2327 |
priceBookValueRatio: | 2.7067 |
priceEarningsRatio: | 22.1710 |
netEarningsPerShare: | 1.8596 |
currency: | USD |